CCEP:LSE

Coca-Cola Europacific Partners plc

Data as of 2026-03-11 - not real-time

£7,640.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Coca‑Cola Europacific Partners (CCEP) is trading at 7,640 GBp, comfortably above its 50‑day (7,091) and 200‑day (6,902) simple moving averages, but just under the 20‑day SMA (7,718), suggesting a short‑term price correction within an overall bullish framework. The RSI sits at 54, indicating neutral momentum, while the MACD histogram is negative and the signal line is bearish, flagging some downside pressure. Fundamentally, the company posted record FY 2025 results – revenue of €20.9 bn (+2.8%) and operating margin of 13.4% (+7.1% YoY) – and announced a €1 bn share‑repurchase programme, underscoring confidence in cash generation. However, the DCF‑derived fair value of ~3,050 GBp is less than half the current price, pointing to a significant valuation gap.
The balance sheet shows strong operating cash flow (€2.95 bn) and free cash flow (€1.67 bn) supporting a 2.34% dividend yield with a modest 48% payout ratio, suggesting dividend sustainability. Low beta (~0.13) and a 30‑day volatility of 23.7% imply limited market sensitivity but notable price swings. Sector‑wise, CCEP benefits from the defensive nature of beverages, yet faces medium regulatory and geographic risks due to diverse European and Pacific markets.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price marginally below 20‑day SMA indicating near‑term consolidation
  • Bearish MACD histogram and negative signal line
  • Strong dividend yield and sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Record earnings growth and expanding operating margins
  • €1 bn share‑buyback enhancing shareholder value
  • Defensive consumer‑staples positioning with low beta

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable cash flow generation supporting dividend and buybacks
  • Valuation premium relative to DCF suggests limited upside
  • Long‑term demand resilience for non‑alcoholic beverages

Key Metrics & Analysis

Financial Health

Revenue Growth0.20%
Profit Margin9.29%
P/E Ratio20.7
ROE22.89%
ROA5.50%
Debt/Equity128.80
P/B Ratio505.5
Op. Cash Flow£3.0B
Free Cash Flow£1.7B

Technical Analysis

TrendBullish
RSI54.5
Support£7,030.00
Resistance£8,270.00
MA 20£7,718.00
MA 50£7,091.80
MA 200£6,901.90
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value£3,049.25
Target Price£7,167.84
Upside/Downside-6.18%
GradeOvervalued
TypeBlend
Dividend Yield2.34%

Risk Assessment

Beta0.13
Volatility23.71%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.